Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma
Smaller enhancer-promoter combinations can be used to deliver larger genes in human cells and for treatment in optic neuropathies including glaucoma.
Authors
- Kenneth S. Shindler (ORCID: https://orcid.org/0000-0003-2417-258X)
- Brahim Chaqour (ORCID: https://orcid.org/0000-0002-8516-4324)
- Kimberly E. Dine (ORCID: https://orcid.org/0000-0001-5569-7261)
- Ahmara G. Ross (ORCID: https://orcid.org/0000-0002-7527-3121)
- Nuala O’Neill
- Neha Sarabu
- Miranda Meng
- Jennifer C. Pham
Institutions
- Penn Presbyterian Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1167/tvst.13.8.37
- Citations
- 4
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- F. M. Kirby Foundation
- Research to Prevent Blindness
- James N. Kirby Foundation
- National Institutes of Health